Synergistic anti-candidal activity and mode of action of Mentha piperita essential oil and its major components

Pharmaceutical Biology

Volumn 53, Issue 10, 2015, Pages 1496-1504

  Samber, Neha ^a,b   Khan, Amber ^a,c   Varma, Ajit ^b   Manzoor, Nikhat ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b AMITY UNIVERSITY   (India)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Antifungal activity; Candida; Carvone; Menthol; Menthone; Plasma membrane H+ ATPase; Synergy; Virulence

Indexed keywords

1 OCTANOL ACETATE; 3 OCTANOL; ANETHOLE; BETA PINENE; CARVONE; CARYOPHYLLENE; CARYOPHYLLENE OXIDE; CINEOLE; CYCLOHEXANOL; DELTA TERPINEOL; FLUCONAZOLE; GERANIOL; ISOMENTHONE; ISOPULEGOL; LIMONENE; LINALOOL; MENTHOL; MENTHONE; MENTHYL ACETATE; MYRCENE; MYRTANOL; NEOISOMENTHOL; OCTANOL; PARA CYMENE; PEPPERMINT OIL; PINENE; PULEGONE; SABINENE; TERPINEOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIFUNGAL AGENT; ESSENTIAL OIL; VEGETABLE OIL;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CELL DEATH; CELL MEMBRANE; CONTROLLED STUDY; CYTOTOXICITY; DRUG IDENTIFICATION; DRUG STRUCTURE; ENZYME ACTIVITY; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; DOSE RESPONSE; DRUG EFFECTS; DRUG POTENTIATION; ISOLATION AND PURIFICATION; MENTHA PIPERITA; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY;

CANDIDA; LAMIACEAE; MENTHA; MENTHA X PIPERITA;

ANTIFUNGAL AGENTS; CANDIDA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; MENTHA PIPERITA; MICROBIAL SENSITIVITY TESTS; OILS, VOLATILE; PLANT OILS;

EID: 84939155753     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.989623     Document Type: Article

References (44)

1. Ahmad A, Khan A, Akhtar F, et al. (2011). Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur J Clin Microbiol Infect Dis 30:41-50.
2. Ahmad A, Khan A, Khan L, Manzoor N. (2010a). In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates. J Med Microbiol 59:1178-84.
3. Ahmad A, Khan A, Manzoor N, Khan LA. (2010b). Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microb Pathog 48:35-41.
4. Ahmad A, Khan A, Yousuf S, et al. (2010c). Proton translocating ATPase mediated fungicidal activity of eugenol and thymol. Fitoterapia 81:1157-62.
5. Arthington-Skaggs BA, Jradi H, Desai T, Morrison CJ. (1999). Quantitation of ergosterol content: Novel method for determination of fluconazole susceptibly of Candida albicans. J Clin Microbiol 37:3332-7.
6. Ben-Josef AM, Manavathu EK, Platt D, Sobel JD. (2000). Proton translocating ATPase mediated fungicidal activity of a novel complex carbohydrate: CAN-296. Int J Antimicrob Agents 13:287-95.
7. Berenbaum MC. (1989). What is synergy? Pharmacol Rev 41:93-141.
8. Burt S. (2004). Essential oils: Their antibacterial properties and potential applications in foods - A review. Int J Food Microbiol 94:223-53.
9. Cantón E, Pemán J, Gobernado M, et al. (2005). Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods. Antimicrob Agents Chemother 49:1593-6.
10. Carretto CFP, Almeida RBA, Furlan MR, et al. (2010). Antimicrobial activity of Mentha piperita L. against Candida spp. Braz Dent Sci 13:4-9.
11. CLSI. (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A3, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute.
12. Cohen ML. (1998). Resurgent and emergent disease in a changing world. Br Med Bull 54:523-32.
13. Cristani M, D'Arrigo M, Mandalari G, et al. (2007). Interaction of four monoterpenes contained in essential oils with model membranes: Implications for their antibacterial activity. J Agric Food Chem 55:6300-8.
14. Derwich E, Benziane Z, Chabir R. (2011). Aromatic and medicinal plants of Morocco: Chemical composition of essential oils of Rosmarinus officinalis and Juniperus phoenicea. IJABPT 2:145-53.
15. Dudhatra GB, Mody SK, Awale MM, et al. (2012). A comprehensive review on pharmacotherapeutics of herbal bioenhancers. Sci World J 2012:1-33.
16. Ghannoum MA, Fu Y, Ibrahim AS, et al. (1995). In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans. Antimicrob Agents Chemother 39:2459-65.
17. Iwu MW, Dunean AR, Okunji CO. (1999). New antimicrobials of plant origin. In: Janick J, ed. Perspectives on New Crop and New Uses. Alexandria: ASHS Press, 457-62.
18. Kaneshima S, Koga S, Tanaka K. (1977). A simple method for cellular identification of free cell by light microscopy and scanning electron microscopy. J Electron Microsc 26:355-8.
19. Kaur S, Mishra P, Prasad R. (1988). Dimorphism associated changes in intracellular pH of Candida albicans. Biochim Biophys Acta 972:277-82.
20. Khan A, Ahmad A, Manzoor N, Khan LA. (2010a). Antifungal activities of Ocimum sanctum essential oil and its lead molecules. Nat Prod Commun 5:345-9.
21. Khan A, Ahmad A, Xess I, et al. (2010b). Anticandidal effect of Ocimum sanctum essential oil and its synergy with fluconazole and ketoconazole. Phytomedicine 17:921-5.
22. Li J, Dong J, Qiu JZ, et al. (2011). Peppermint oil decreases the production of virulence-associated exoproteins by Staphylococcus aureus. Molecules 16:1642-54.
23. Lucchini JJ, Corre J, Cremieux A. (1990). Antibacterial activity of phenolic compounds and aromatic alcohols. Res Microbiol 141:499-510.
24. Manavathu EK, Dimmock JR, Vashishtha SC, Chandrasekar PH. (1999). Proton-pumping-ATPase-targeted antifungal activity of a novel conjugated styryl ketone. Antimicrob Agents Chemother 43:2950-9.
25. Manzoor N, Amin M, Khan LA. (2002). Effect of phosphocreatine on H+ extrusion, pHi and dimorphism in Candida albicans. Indian J Exp Biol 40:785-90.
26. Mares D. (1989). Electron microscopy of Microsporum cookie after in vitro treatment with protoanemonin: A combined SEM and TEM study. Mycopatholgia 108:37-47.
27. Maschmeyer G. (2006). The changing epidemiology of invasive fungal infections: New threats. Int J Antimicrob Agents 27:3-6.
28. Matasyoh JC, Maiyo ZC, Ngure RM, Chepkorir R. (2009). Chemical composition and antimicrobial activity of essential oil of Coriandrum sativum. Food Chem 113:526-9.
29. Mukherjee PK, Sheehan DJ, Hitchcock CA, Ghannoum MA. (2005). Combination treatment of invasive fungal infections. Clin Microbiol Rev 18:163-94.
30. Palmeira-De-Oliveira A, Salgueiro L, Palmeira-De-Oliveira R, et al. (2009). Anti-Candida activity of essential oils. Mini Rev Med Chem 9:1292-305.
31. Perlin DS, Seto-Young D, Monk BC. (2006). The plasma membrane H+ ATPase of fungi. A candidate drug target? Ann NY Acad Sci 834:609-17
32. Pfaller MA, Diekema DJ. (2004). Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigates. J Clin Microbiol 42:4419-31.
33. Pinto E, Vale-Silva L, Cavaleiro C, Salgueiro L. (2009). Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and Dermatophyte species. J Med Microbiol 58:1454-62.
34. Saharkhiz MJ, Motamedi M, Zomorodian K, et al. (2012). Chemical composition, antifungal and antibiofilm activities of the essential oil of Mentha piperita L. ISRN Pharm 2012:1-6.
35. Sandasi M, Leonard CM, Van-Vuuren SF, Viljoen AM. (2011). Peppermint (Mentha piperita) inhibits microbial biofilms in vitro. South Afr J Bot 77:80-5.
36. Sanglard D, Ischer F, Parkinson T, et al. (2003). Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother 47:2404-12.
37. Serrano R. (1983). In vivo glucose activation of the yeast plasma membrane ATPase. FEBS Lett 156:11-14.
38. + ATPase of fungi. Biochim Biophys Acta 1326:249-56.
39. Stewart E, Gow NA, Bowen DV. (1988). Cytoplasmic alkalinization during germ tube formation in Candida albicans. J Gen Microbiol 134:1079-87.
40. Tariq VN, Scott EM, McCain NE. (1995). Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against C. albicans in vitro. Antimicrob Agents Chemother 39:2615-19.
41. Uppuluri P, Nett J, Heitman J, Andes D. (2008). Synergistic effect of calcineurin inhibitors and fluconazole against C. albicans biofilms. Antimicrob Agents Chemother 52:1127-32.
42. Vanden Bossche H. (1985). Biochemical targets for antifungal azole derivatives: Hypothesis on the mode of action. Curr Top Med Mycol 1:313-51.
43. Xu J, Zhou F, Ji BP, et al. (2008). The antibacterial mechanism of carvacrol and thymol against Escherichia coli. Lett Appl Microbiol 47:174-9.
44. Yatime L, Pedersen MJ, Musgaard M, et al. (2009). P-type ATPase as drug targets: Tools for medicine and science. Biochim Biophys Acta 1787:207-20.